NRx Pharmaceuticals (NRXP) Institutional Ownership $2.07 +0.09 (+4.55%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for NRx Pharmaceuticals (NASDAQ:NRXP)CurrentInstitutional OwnershipPercentage4.27%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$907.12KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.54M Get NRXP Insider Trade Alerts Want to know when executives and insiders are buying or selling NRx Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NRXP Institutional Buying and Selling by Quarter NRx Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Squarepoint Ops LLC25,299$56K0.0%N/A0.161% 2/17/2025Millennium Management LLC27,624$61K0.0%N/A0.176% 2/17/2025Anson Funds Management LP185,660$408K0.0%+30.3%1.183% 2/14/2025AdvisorShares Investments LLC310,314$683K0.1%+138.5%1.977% 2/14/2025Sassicaia Capital Advisers LLC15,000$33K0.8%N/A0.096% 11/15/2024Anson Funds Management LP142,525$241K0.0%N/A1.326% 11/13/2024Townsquare Capital LLC15,041$25K0.0%N/A0.140% 8/8/2024AdvisorShares Investments LLC108,085$279K0.0%-82.4%1.010% 8/6/2024One Wealth Management Investment & Advisory Services LLC15,041$37K0.0%-89.3%0.141% 2/14/2024AdvisorShares Investments LLC642,632$296K0.1%N/A0.755% Get the Latest News and Ratings for NRXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NRx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/25/2024One Wealth Management Investment & Advisory Services LLC140,402$65K0.0%N/A0.165% 11/15/2023Sabby Management LLC325,000$84K0.1%-53.6%0.398% 5/1/2023Virtu Financial LLC46,210$30K0.0%N/A0.065% 2/9/2023HBK Sorce Advisory LLC58,460$65K0.0%N/A0.086% 1/31/2023AE Wealth Management LLC29,515$33K0.0%N/A0.044% 1/27/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 1/18/2023 Exchange Traded Concepts LLC26,924$30K0.0%+154.0%0.040% 11/3/2022Texas Capital Bank Wealth Management Services Inc.63,290$47K0.0%N/A0.094% 5/18/2022Ursa Fund Management LLC15,000$37K0.0%N/A0.023% 4/29/2022United Asset Strategies Inc.18,300$45K0.0%N/A0.027% 2/9/2022Wolverine Asset Management LLC37,105$177K0.0%-12.8%0.063% 2/8/2022Raymond James Financial Services Advisors Inc.11,567$55K0.0%N/A0.020% 11/15/2021Penserra Capital Management LLC2,956$27K0.0%N/A0.005% 11/12/2021Wolverine Asset Management LLC42,568$394K0.0%+118.4%0.079% 11/5/2021Advisor Group Holdings Inc.42,885$398K0.0%+1,197.6%0.080% 11/2/2021 Cambridge Investment Research Advisors Inc.153,523$1.42M0.0%N/A0.285% 8/16/2021Owl Creek Asset Management L.P.300,000$3.40M0.2%N/A0.626% 8/16/2021Ionic Capital Management LLC35,721$415K0.0%N/A0.075% 8/16/2021Linden Advisors LP364,352$4.23M0.0%N/A0.760% 8/13/2021Northern Trust Corp130,633$1.52M0.0%N/A0.273% 8/13/2021Yakira Capital Management Inc.11,923$139K0.0%N/A0.025% 8/13/2021Geode Capital Management LLC34,475$400K0.0%N/A0.072% 8/13/2021Vanguard Group Inc.637,416$7.41M0.0%N/A1.330% (Data available from 1/1/2016 forward) NRXP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NRXP shares? During the previous two years, 9 institutional investors and hedge funds held shares of NRx Pharmaceuticals. The most heavily invested institutionals were AdvisorShares Investments LLC ($683K), Anson Funds Management LP ($408K), Sabby Management LLC ($84K), Millennium Management LLC ($61K), Squarepoint Ops LLC ($56K), One Wealth Management Investment & Advisory Services LLC ($37K), and Sassicaia Capital Advisers LLC ($33K).Learn more on NRXP's institutional investors. What percentage of NRx Pharmaceuticals stock is owned by institutional investors? 4.27% of NRx Pharmaceuticals stock is owned by institutional investors. Learn more on NRXP's institutional investor holdings. Which institutional investors have been buying NRx Pharmaceuticals stock? The following institutional investors have purchased NRx Pharmaceuticals stock in the last 24 months: AdvisorShares Investments LLC ($822.86K), Anson Funds Management LP ($185.66K), One Wealth Management Investment & Advisory Services LLC ($140.40K), Virtu Financial LLC ($46.21K), Millennium Management LLC ($27.62K), Squarepoint Ops LLC ($25.30K), and Townsquare Capital LLC ($15.04K). How much institutional buying is happening at NRx Pharmaceuticals? Institutional investors have bought a total of 1,278,097 shares in the last 24 months. This purchase volume represents approximately $39.97M in transactions. Which NRx Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold NRx Pharmaceuticals stock in the last 24 months: AdvisorShares Investments LLC ($506.71K), Sabby Management LLC ($374.73K), and One Wealth Management Investment & Advisory Services LLC ($125.36K). How much institutional selling is happening at NRx Pharmaceuticals? Institutional investors have sold a total of 1,006,800 shares in the last 24 months. This volume of shares sold represents approximately $11.29M in transactions. Related Companies Organigram Major Shareholders Lyell Immunopharma Major Shareholders scPharmaceuticals Major Shareholders Aclaris Therapeutics Major Shareholders ProQR Therapeutics Major Shareholders RAPT Therapeutics Major Shareholders Greenwich LifeSciences Major Shareholders 4D Molecular Therapeutics Major Shareholders Nkarta Major Shareholders Korro Bio Major Shareholders This page (NASDAQ:NRXP) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored‘Wheels Are Falling Off’ the U.S. Stock MarketThe last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.